Recombinant Porcine PD-L1/B7-H1 Fc Chimera Protein, CF

Recombinant Porcine PD-L1/B7-H1 Fc Chimera Protein, CF Summary

Product Specifications

Product Datasheets

Carrier Free

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

Background: PD-L1/B7-H1

Programmed cell death 1 ligand 1 (PD-L1), also known as B7-H1 and CD274, is a transmembrane glycoprotein and a member of the B7 family of immune regulatory molecules within the immunoglobulin (Ig) superfamily (1). Mature porcine PD-L1 consists of an extracellular domain (ECD) with both an Ig-V and Ig-C-like motif, a single transmembrane domain, and a short cytoplasmic tail lacking a canonical signaling motif (1). The mature ECD of porcine PD-L1 shares 74% and 67% amino acid sequence identity with human and mouse B7-H1, respectively. Alternative splicing of PD-L1 generates additional isoforms that either lack the first Ig-like domain or are truncated within the second Ig-like domain (2). B7-H1 is expressed on inflammatory-activated immune cells including macrophages, T cells, and B cells, keratinocytes, endothelial and intestinal epithelial cells, as well as a variety of carcinomas and melanoma (3-9). B7-H1 binds to T cell B7-1/CD80 and PD-1 (7-9). It suppresses T cell activation and proliferation and induces the apoptosis of activated T cells (6, 10). It plays a role in the development of immune tolerance by promoting T cell anergy and enhancing regulatory T cell development (9). B7-H1 favors the development of anti-inflammatory IL-10 and IL-22 producing dendritic cells and inhibits the development of Th17 cells (5, 10). In cancer, B7-H1 provides resistance to T cell mediated lysis, enhances EMT, and enhances the tumorigenic function of Th22 cells (3-4, 7, 9).

Related Research Areas

• Co-stimulatory and Co-inhibitory Molecules
• Co-stimulatory Molecules Associated with Tfh Cells
• Epithelial Cell Markers and Intracellular Molecules
• Myeloid-derived Suppressor Cells (MDSC)
• Regulatory T Cells (Tregs)
• Search Immune Checkpoint Targets
• Surface Ectodermal Cells